Join
Live feed
·
INSIDERFilingvia Quantisnow
Pardes Biosciences Inc. logo

SEC Form 4: Wiggans Thomas G bought $13,625 worth of shares (12,500 units at $1.09), increasing direct ownership by 33% to 50,000 units

ByQuantisnow·Wall Street's wire, on your screen.
PRDS· Pardes Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRDS (Pardes Biosciences Inc.) and more on Quantisnow.